Abstract
1. A stereospecific h.p.l.c. assay of nicoumalone in plasma has been developed. 2. The assay was applied to a study in which 20 mg racemic nicoumalone was given orally to three volunteers and blood samples taken for 168 h. 3. The mean pharmacokinetic parameters of the individual enantiomers were: clearance/bioavailability 1.28 1 h-1, R-enantiomer; 17.5 1 h-1, S-enantiomer: volume of distribution/bioavailability 12.5 1, R-enantiomer; 22.6 1, S-enantiomer: terminal half-life 6.8 h, R-enantiomer; 0.91 h, S-enantiomer. 4. The data are consistent with a substantial first-pass hepatic loss of S-nicoumalone.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Banfield C., O'Reilly R., Chan E., Rowland M. Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations. Br J Clin Pharmacol. 1983 Dec;16(6):669–675. doi: 10.1111/j.1365-2125.1983.tb02239.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Banfield C., Rowland M. Stereospecific fluorescence high-performance liquid chromatographic analysis of warfarin and its metabolites in plasma and urine. J Pharm Sci. 1984 Oct;73(10):1392–1396. doi: 10.1002/jps.2600731017. [DOI] [PubMed] [Google Scholar]
- Dieterle W., Faigle J. W., Montigel C., Sulc M., Theobald W. Biotransformation and pharmacokinetics of acenocoumarol (Sintrom) in man. Eur J Clin Pharmacol. 1977;11(5):367–375. doi: 10.1007/BF00566534. [DOI] [PubMed] [Google Scholar]
- Gibaldi M., Boyes R. N., Feldman S. Influence of first-pass effect on availability of drugs on oral administration. J Pharm Sci. 1971 Sep;60(9):1338–1340. doi: 10.1002/jps.2600600909. [DOI] [PubMed] [Google Scholar]
- Godbillon J., Richard J., Gerardin A., Meinertz T., Kasper W., Jähnchen E. Pharmacokinetics of the enantiomers of acenocoumarol in man. Br J Clin Pharmacol. 1981 Nov;12(5):621–629. doi: 10.1111/j.1365-2125.1981.tb01280.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Oie S., Tozer T. N. Effect of altered plasma protein binding on apparent volume of distribution. J Pharm Sci. 1979 Sep;68(9):1203–1205. doi: 10.1002/jps.2600680948. [DOI] [PubMed] [Google Scholar]